The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
SARS-CoV-2 Variants and Vaccines
Open accessAbstract
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Bernal, J. L., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · doi:10.1101/2021.05.22.21257658 · Cited by 2,888
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Wang, P., Nair, M. S., Liu, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P. D., et al. (2021) · Nature · doi:10.1038/s41586-021-03398-2 · Cited by 2,312
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. D. S., Mishra, S., Crispim, M. A. E., Sales, F. C. S., Hawryluk, I., McCrone, J. T., et al. (2021) · Science · doi:10.1126/science.abh2644 · Cited by 1,461
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097
Muñoz-Fontela, C., Dowling, W. E., Funnell, S. G. P., Gsell, P.-S., Riveros-Balta, A. X., Albrecht, R. A., Andersen, H., Baric, R. S., Carroll, M. W., Cavaleri, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2787-6 · Cited by 798
Self-citationHenao-Restrepo, A. M., Longini, I. M., Egger, M., Dean, N. E., Edmunds, W. J., Camacho, A., Carroll, M. W., Doumbia, M., Draguez, B., Duraffour, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61117-5 · Cited by 793
Self-citationThe Magic of Randomization versus the Myth of Real-World Evidence
Collins, R., Bowman, L., Landray, M., & Peto, R. (2020) · New England Journal of Medicine · doi:10.1056/nejmsb1901642 · Cited by 478
Self-citationGenomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., Radhakrishnan, V., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · doi:10.1101/2021.06.02.21258076 · Cited by 296
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., VS, R., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · Science · doi:10.1126/science.abj9932 · Cited by 296
De Serres, G., Skowronski, D. M., Wu, X. W., & Ambrose, C. S. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.37.20585 · Cited by 245
MacIntyre, C. R., Costantino, V., & Trent, M. (2022) · Vaccine · doi:10.1016/j.vaccine.2021.04.042 · Cited by 166
World war I may have allowed the emergence of “Spanish” influenza.
Oxford, J., Sefton, A., Jackson, R., Innes, W., Daniels, R., & Johnson, N. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00185-8 · Cited by 139
COVID-19 vaccine trials should seek worthwhile efficacy
Krause, P. R., Fleming, T. R., Longini, I. M., Restrepo, A. M. H., Peto, R., Dean, N. E., Halloran, M., Huang, Y., Fleming, T., Gilbert, P., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31821-3 · Cited by 127
Self-citationMeasurement of Vaccine Direct Effects Under the Test-Negative Design
Lewnard, J. A., Tedijanto, C., Cowling, B. J., & Lipsitch, M. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy163 · Cited by 124
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation (2021) · New England Journal of Medicine · doi:10.1056/nejmp2033538 · Cited by 85
Covid-19: WHO warns against “vaccine nationalism” or face further virus mutations
Eaton, L. (2021) · BMJ · doi:10.1136/bmj.n292 · Cited by 71
Gilbert, P. B., Self, S. G., Rao, M. R., Naficy, A. B., & Clemens, J. D. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00258-4 · Cited by 70
COVID-19 vaccine trials: The use of active controls and non-inferiority studies
Fleming, T. R., Krause, P. R., Nason, M., Longini, I. M., & Restrepo, A. M. H. (2021) · Clinical Trials · doi:10.1177/1740774520988244 · Cited by 28
Self-citationTemporal Confounding in the Test-Negative Design
Dean, N. E., Halloran, M. E., & Longini, I. M. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa084 · Cited by 19
Self-citation
Cited by
The biological and clinical significance of emerging SARS-CoV-2 variants
Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009
Araf, Y., Akter, F., Tang, Y., Fatemi, R., Parvez, M. S. A., Zheng, C., & Hossain, M. G. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27588 · Cited by 862
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Dunkle, L. M., Kotloff, K. L., Gay, C. L., Áñez, G., Adelglass, J. M., Barrat Hernández, A. Q., Harper, W. L., Duncanson, D. M., McArthur, M. A., Florescu, D. F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116185 · Cited by 443
Human genetic and immunological determinants of critical COVID-19 pneumonia
Zhang, Q., Bastard, P., Effort, C. H. G., Karbuz, A., Gervais, A., Tayoun, A. A., Aiuti, A., Belot, A., Bolze, A., Gaudet, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04447-0 · Cited by 366
Vuong, Q.-H., Le, T.-T., La, V.-P., Nguyen, H. T. T., Ho, M.-T., Van Khuc, Q., & Nguyen, M.-H. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01034-6 · Cited by 344
Metadata
- Authors
- Krause, P. R., Fleming, T. R., Longini, I. M., Peto, R., Briand, S., Heymann, D. L., Beral, V., Snape, M. D., Rees, H., Ropero, A.-M., Balicer, R. D., Cramer, J. P., Muñoz-Fontela, C., Gruber, M., Gaspar, R., Singh, J. A., Subbarao, K., Van Kerkhove, M. D., Swaminathan, S., Ryan, M. J., & Henao-Restrepo, A.-M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-07-08
- Volume
- 385
- Issue
- 2
- Pages
- 179-186
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3176225922
- Cited by
- 366
- References
- 21
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.